Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-22 1:34 pm Sale |
2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 379,702 6.100% |
-14,943 (-3.79%) |
Filing History |
| 2022-02-14 10:20 am Purchase |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Nestle Health Science US Holdings Inc. | 3,730,841 9.580% |
3,730,841 (New Position) |
Filing History |
| 2020-09-09 8:00 pm Unchanged |
2020-09-08 | 13G | Axcella Health Inc. AXLA |
Nestle Health Science US Holdings Inc. | 172,222 11.810% |
0 (Unchanged) |
Filing History |
| 2020-08-19 5:17 pm Purchase |
2020-08-17 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 394,645 8.800% |
394,645 (New Position) |
Filing History |